METTL1 and neoplasm: However, current research faces significant limitations, particularly the incomplete understanding of specific mechanisms by which METTL1 alters the tumor microenvironment and other oncogenic factors, as these interactions remain poorly elucidated and hinder the development of robust combination therapies 18.